Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Korro Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 58 | 55 | −3 |
| Shares | 8.68M | 7.89M | −791.0K (−9.1%) |
| Value | $13.0M | $14.1M | +$1.10M (+8.5%) |
New holders (6)
Institutions that held Korro Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 24,624 | $44.0K | 0.00% |
| Charles Schwab Investment Management Inc | 23,364 | $42.0K | 0.00% |
| Brown Advisory Inc | 19,795 | $35.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 12,887 | $23.0K | 0.00% |
| Balyasny Asset Management LLC | 11,731 | $21.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 330 | $1.00K | 0.00% |
Sold out (9)
Institutions that held Korro Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Voya Investment Management LLC | 104,984 | $157.0K |
| AQR Capital Management LLC | 100,820 | $151.0K |
| Prudential Financial Inc | 23,700 | $36.0K |
| Duncker Streett & Co Inc | 15,766 | $24.0K |
| Captrust Financial Advisors | 9,488 | $14.0K |
| Legal & General Group Plc | 2,554 | $4.00K |
| Prospera Financial Services Inc | 1,000 | $2.00K |
| FNY Investment Advisers, LLC | 1,500 | $2.00K |
| New York State Common Retirement Fund | 270 | $0 |